Key Features

  • Nodule malignancy similarity score

General Information

Product name

RevealAI-Lung

Company

Subspeciality

Chest

Modality

CT

Disease targeted

Lung cancer

Main task

Not specified

Technical Specifications

Population

Incidental nodules and those found during screening

Patient population age

Not specified

Input

CT, 3D, contrast, non-contrast

Input format

DICOM

Output

Malignancy Similarity Index (mSI)

Output format

To be determined

Integration

Integration in standard reading environment (PACS)

Deployment

Cloud-based, Locally on dedicated hardware

Trigger for analysis

Etc., Image upload, On demand, Triggered by a user through e.g. a button click

Processing time

< 3 sec

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

05-2021

AI Platforms

Not specified

Resellers

Amplify SDK, Contextflow, Riverain Technologies

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

2

Pricing Information

Pricing model

Pay-per-use, Subscription

Based on

Number of analyses

Evidence & Research

Peer-Reviewed Papers

Peer-Reviewed

View

Clinical Impact and Generalizability of a Computer-Assisted Diagnostic Tool to Risk-Stratify Lung Nodules With CT

Source: vendor | First published: Sep 27, 2022 | Last updated: Jul 9, 2025